In androgen-treated cells, cPAcP is down-regulated, which correlates with ErbB-2 and ERK/MAP kinases activation for promoting PCa cell proliferation (Fig. 2) [26], [27], [51]. This evidence concerns the gene ERBB2 and posterior cortical atrophy.